PharmaShots | Incisive News in 3 Shots

Subscribe Now

Tempo Therapeutics

Tempo Therapeutics Reports the First Patient Dosing in the MOSAIC Trial of TT101 for Tissue Repair in Skin Cancer Surgery

Tempo Therapeutics Reports the First Patient Dosing in the MOSAIC Trial of TT101 for Tissue Repair in Skin Cancer Surgery

September 6, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us